Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Type I collagen gel is a biomaterial formulation composed of type I collagen, the primary structural protein found in the extracellular matrix of connective tissues. In clinical settings, it is utilized for its biocompatibility and scaffold-forming properties to support tissue repair and regeneration. The gel acts by providing immediate mechanical reinforcement to weakened or damaged tissues and by creating a microenvironment that encourages cellular migration, proliferation, and the deposition of new endogenous collagen. It is currently being investigated as a therapeutic intervention for female pelvic floor dysfunctions, including pelvic organ prolapse and stress urinary incontinence, where it aims to restore the structural integrity of the pelvic support structures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on type I collagen gel.